Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis Fulltext Access 8 Pages 2006
Long-term egg-yolk adaptation of the Orientia tsutsugamushi for preparation of a formalinized immunogen Fulltext Access 8 Pages 2006
Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice Fulltext Access 8 Pages 2006
Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(dl-lactide-co-glycolide) microspheres Fulltext Access 8 Pages 2006
Immunologic responses of bison to vaccination with Brucella abortus strain RB51: Comparison of parenteral to ballistic delivery via compressed pellets or photopolymerized hydrogels Fulltext Access 8 Pages 2006
Haemolytic activities and adjuvant effect of Bupleurum chinense saponins on the immune responses to ovalbumin in mice Fulltext Access 8 Pages 2006
Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs Fulltext Access 8 Pages 2006
Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice Fulltext Access 8 Pages 2006
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens Fulltext Access 8 Pages 2006
Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity Fulltext Access 8 Pages 2006
HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics Fulltext Access 8 Pages 2006
Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco Fulltext Access 8 Pages 2006
Immunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice Fulltext Access 8 Pages 2006
Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2–7 months of age Fulltext Access 8 Pages 2006
Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant Fulltext Access 8 Pages 2006
Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8–12-year-old children Fulltext Access 8 Pages 2006
Immune response induced by Salmonella typhimurium defective in ppGpp synthesis Fulltext Access 8 Pages 2006
Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert Fulltext Access 8 Pages 2006
Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults Fulltext Access 8 Pages 2006
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment Fulltext Access 8 Pages 2006
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate Fulltext Access 8 Pages 2006
Starch microparticles as a vaccine adjuvant: Only uptake in Peyer's patches decides the profile of the immune response Fulltext Access 8 Pages 2006
Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette–Guèrin expressing malarial and tuberculosis epitopes Fulltext Access 8 Pages 2006
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice Fulltext Access 8 Pages 2006
Age-specific changes in the female–male mortality ratio related to the pattern of vaccinations: An observational study from rural Gambia Fulltext Access 8 Pages 2006
Replication and immunoactivity of the recombinant Peromyscus maniculatus cytomegalovirus expressing hantavirus G1 glycoprotein in vivo and in vitro Fulltext Access 8 Pages 2006
Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis Fulltext Access 8 Pages 2006
Immunogenicity and cytoadherence of recombinant heparin binding haemagglutinin (HBHA) of Mycobacterium avium subsp. paratuberculosis: Functional promiscuity or a role in virulence? Fulltext Access 8 Pages 2006
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? Fulltext Access 8 Pages 2006
Phase II randomized, placebo-controlled trial of M. vaccae-derived protein (PVAC®) for the treatment of psoriasis Fulltext Access 8 Pages 2006
Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope Fulltext Access 8 Pages 2006
Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice Fulltext Access 8 Pages 2006
Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer Fulltext Access 8 Pages 2006
Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes Fulltext Access 8 Pages 2006
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children Fulltext Access 8 Pages 2006
Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette–guerin in mice Fulltext Access 8 Pages 2006
Heat labile enterotoxin of E. coli: a potential adjuvant for transcutaneous cancer immunotherapy Fulltext Access 8 Pages 2006
Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge Fulltext Access 8 Pages 2006
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection Fulltext Access 8 Pages 2006
Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan Fulltext Access 8 Pages 2006
Efficacy of strain RB51 vaccine in heifers against experimental brucellosis Fulltext Access 8 Pages 2006
The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant Fulltext Access 8 Pages 2006
Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection Fulltext Access 8 Pages 2006
Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies Fulltext Access 8 Pages 2006
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine Fulltext Access 8 Pages 2006
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential Fulltext Access 8 Pages 2006
Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice Fulltext Access 8 Pages 2006
Reassortment between human A(H3N2) viruses is an important evolutionary mechanism Fulltext Access 8 Pages 2006
Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: Comparison with Glaxo-Evans 1077 BCG vaccine Fulltext Access 8 Pages 2006
Vaccinia scars associated with better survival for adults: An observational study from Guinea-Bissau Fulltext Access 8 Pages 2006
BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components Fulltext Access 8 Pages 2006
Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen Fulltext Access 8 Pages 2006
Evidence of a cross-protective immune response to influenza A in the cotton rat model Fulltext Access 8 Pages 2006
Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1) Fulltext Access 8 Pages 2006
The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence Fulltext Access 8 Pages 2006
Vaccination with Setaria cervi 175 kDa collagenase induces high level of protection against Brugia malayi infection in jirds Fulltext Access 8 Pages 2006
Nano- and microparticles as adjuvants in vaccine design: Success and failure is related to host natural antibodies Fulltext Access 8 Pages 2006
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men Fulltext Access 8 Pages 2006
Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage Fulltext Access 8 Pages 2006
Sense and the science of childhood immunization: Can we achieve more with less? Fulltext Access 8 Pages 2006
Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity Fulltext Access 8 Pages 2006
A survey of UK parental attitudes to the MMR vaccine and trust in medical authority Fulltext Access 8 Pages 2006
Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers Fulltext Access 8 Pages 2006
Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groups Fulltext Access 8 Pages 2006
Intranasal Protollin™/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection Fulltext Access 8 Pages 2006
Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults Fulltext Access 8 Pages 2006
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG Fulltext Access 8 Pages 2006
How many infective viral particles are necessary for successful mass measles immunization by aerosol? Fulltext Access 8 Pages 2006
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x) Fulltext Access 8 Pages 2006
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2 Fulltext Access 8 Pages 2006
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers Fulltext Access 8 Pages 2006
Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis Fulltext Access 8 Pages 2006
Human immune response towards recombinant Helicobacter pylori urease and cellular fractions Fulltext Access 8 Pages 2006
Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses Fulltext Access 8 Pages 2006
Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model Fulltext Access 8 Pages 2006
Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits Fulltext Access 8 Pages 2006
Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination Fulltext Access 8 Pages 2006
Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice Fulltext Access 8 Pages 2006
Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device Fulltext Access 8 Pages 2006
Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis Fulltext Access 8 Pages 2006
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers Fulltext Access 8 Pages 2006
Local immune responses following nasal delivery of an adjuvanted influenza vaccine Fulltext Access 8 Pages 2006
The MMR vaccination and autism controversy in United Kingdom 1998–2005: Inevitable community outrage or a failure of risk communication? Fulltext Access 8 Pages 2006
Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults Fulltext Access 8 Pages 2006
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model Fulltext Access 8 Pages 2006
A mutant of Escherichia coli enterotoxin inducing a specific Thl-type of T cells to varicella-zoster vaccine enhances the production of IL-12 by IFNγ-stimulated macrophages Fulltext Access 8 Pages 2006
Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse Fulltext Access 8 Pages 2006
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments Fulltext Access 8 Pages 2006
Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2 Fulltext Access 8 Pages 2006
What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study Fulltext Access 8 Pages 2006
A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine Fulltext Access 8 Pages 2006
Analysis of the young and elderly variable gene repertoire in response to pneumococcal polysaccharides using a reconstituted SCID mouse model Fulltext Access 8 Pages 2006
Interferon-γ dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines Fulltext Access 8 Pages 2006
Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis Fulltext Access 8 Pages 2006